Trials / Conditions / Solid Tumors, KRAS Mutation
Solid Tumors, KRAS Mutation
3 registered clinical trials studyying Solid Tumors, KRAS Mutation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different NCT04973163 | Boehringer Ingelheim | Phase 1 |
| Terminated | A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients W NCT04835714 | Boehringer Ingelheim | Phase 1 |
| Completed | A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS NCT04742556 | Boehringer Ingelheim | Phase 1 |